KALA BIO Amends $350M Shelf Registration to Reflect 1-for-50 Reverse Stock Split
KALA sits 27% above its 52-week low of $2.03 on elevated volume (2.4× avg).
Summary
KALA BIO filed an amendment to its $350 million universal shelf registration, updating it to reflect the recent 1-for-50 reverse stock split and enabling future capital raises under the new share structure.
Key Events · Financing and Capital Events · KALA
-
Shelf Registration Updated
The company amended its universal shelf registration statement for up to $350 million in various securities. This updates the existing shelf, originally filed on May 7, 2026, to align with the company's new capital structure.
-
Reflects Reverse Stock Split
The amendment formally incorporates the 1-for-50 reverse stock split, effective May 8, 2026, which significantly reduced the number of outstanding shares from 929,491,578 to 18,589,787.
-
Significant Potential Dilution
The $350 million shelf represents a substantial amount relative to the company's market capitalization, indicating a high potential for dilution if the securities are issued.
-
Enables Future Capital Raises
This amendment is a critical step to allow KALA BIO to access capital under the existing shelf registration, which is important given the company's ongoing financial challenges and business transition.
Analysis · KALA · Life Sciences
This amendment updates the company's existing $350 million universal shelf registration to reflect the recent 1-for-50 reverse stock split. While not a new capital raise, this filing is a necessary administrative step to enable future offerings under the shelf. The potential for $350 million in new securities represents a substantial amount relative to the company's current market capitalization, indicating significant potential dilution for existing shareholders if fully utilized. This capital access is critical for KALA BIO, which has disclosed going concern doubts and is transitioning its business model.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KALA was trading at $2.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $48.9M. The 52-week trading range was $2.03 to $1,030.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.